Literature DB >> 22763347

Long-term medical management of the liver transplant recipient: what the primary care physician needs to know.

Siddharth Singh1, Kymberly D Watt.   

Abstract

Recognition, management, and prevention of medical complications and comorbidities after liver transplant is the key to improved long-term outcomes. Beyond allograft-related complications, metabolic syndrome, cardiovascular disease, renal dysfunction, and malignancies are leading causes of morbidity and mortality in this patient population. Primary care physicians have an important role in improving outcomes of liver transplant recipients and are increasingly relied on for managing these complex patients. This review serves to assist the primary care physician in the long-term management issues of liver transplant recipients.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763347      PMCID: PMC3498400          DOI: 10.1016/j.mayocp.2012.02.021

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  76 in total

1.  Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.

Authors:  D A Neal; A E Gimson; P Gibbs; G J Alexander
Journal:  Liver Transpl       Date:  2001-06       Impact factor: 5.799

2.  Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.

Authors:  M J Contos; W Cales; R K Sterling; V A Luketic; M L Shiffman; A S Mills; R A Fisher; J Ham; A J Sanyal
Journal:  Liver Transpl       Date:  2001-04       Impact factor: 5.799

3.  Approach to the patient with new-onset diabetes after transplant (NODAT).

Authors:  James T Lane; Samuel Dagogo-Jack
Journal:  J Clin Endocrinol Metab       Date:  2011-11       Impact factor: 5.958

Review 4.  De novo malignancies after liver transplantation: a major cause of late death.

Authors:  J J Fung; A Jain; E J Kwak; S Kusne; I Dvorchik; B Eghtesad
Journal:  Liver Transpl       Date:  2001-11       Impact factor: 5.799

5.  Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.

Authors:  M Charlton; P Kasparova; S Weston; K Lindor; Y Maor-Kendler; R H Wiesner; C B Rosen; K P Batts
Journal:  Liver Transpl       Date:  2001-07       Impact factor: 5.799

6.  Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

Authors:  H J Schlitt; A Barkmann; K H Böker; H H Schmidt; N Emmanouilidis; J Rosenau; M J Bahr; G Tusch; M P Manns; B Nashan; J Klempnauer
Journal:  Lancet       Date:  2001-02-24       Impact factor: 79.321

7.  Hyperuricemia, gout, and renal function after liver transplantation.

Authors:  D A Neal; B D Tom; A E Gimson; P Gibbs; G J Alexander
Journal:  Transplantation       Date:  2001-11-27       Impact factor: 4.939

8.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

9.  Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study.

Authors:  G Leidig-Bruckner; S Hosch; P Dodidou; D Ritschel; C Conradt; C Klose; G Otto; R Lange; L Theilmann; R Zimmerman; M Pritsch; R Ziegler
Journal:  Lancet       Date:  2001-02-03       Impact factor: 79.321

10.  Outcome of liver transplantation in patients with diabetes mellitus: a case-control study.

Authors:  P R John; P J Thuluvath
Journal:  Hepatology       Date:  2001-11       Impact factor: 17.425

View more
  17 in total

Review 1.  [Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].

Authors:  A K Berger; D Jäger
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

Review 2.  Machine perfusion in solid organ transplantation: where is the benefit?

Authors:  Helge Bruns; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2014-01-16       Impact factor: 3.445

Review 3.  Post-transplant dyslipidemia: Mechanisms, diagnosis and management.

Authors:  Arnav Agarwal; G V Ramesh Prasad
Journal:  World J Transplant       Date:  2016-03-24

Review 4.  Treatment of Dyslipidemia in Common Liver Diseases.

Authors:  Elizabeth K Speliotes; Maya Balakrishnan; Lawrence S Friedman; Kathleen E Corey
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-21       Impact factor: 11.382

5.  Medical Management of Metabolic Complications of Liver Transplant Recipients.

Authors:  Abbey Barnard; Peter Konyn; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-10

6.  Laparoscopic Sleeve Gastrectomy for Morbid Obesity in Patients After Orthotopic Liver Transplant: a Matched Case-Control Study.

Authors:  Levan Tsamalaidze; John A Stauffer; Lisa C Arasi; Diego E Villacreses; Jose Salvador Serrano Franco; Steven Bowers; Enrique F Elli
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

Review 7.  Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study.

Authors:  Giuseppina Pisano; Anna L Fracanzani; Lucio Caccamo; Maria F Donato; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2016-10-28       Impact factor: 5.742

Review 8.  Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant.

Authors:  Stefano Gitto; Erica Villa
Journal:  Int J Mol Sci       Date:  2016-04-02       Impact factor: 5.923

9.  Post-operative hypertension, a surrogate marker of the graft function and predictor of survival in living donor liver transplant recipients: A retrospective study.

Authors:  Manish Tandon; Anshuman Singh; Vandana Saluja; Gaurav Dubey; Vijay Kant Pandey; Chandra Kant Pandey; Sunaina Tejpal Karna; Shweta A Singh
Journal:  Indian J Anaesth       Date:  2016-07

Review 10.  Challenging hepatitis C-infected liver transplant patients.

Authors:  Madeleine Oliver; Christopher Chiodo Ortiz; Jorge Ortiz
Journal:  Hepat Med       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.